Navigation Links
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
Date:4/1/2008

vs. 13.5% (p<0.001) for >/=3.5mm-<4.0mm, and 1.6% vs. 6.5% (p<0.05) for >4.0mm. These rates correspond to reductions of 52.5% for the <3.5mm group, 66.7% for the >/=3.5mm-<4.0mm group, and 75.4% for the >/=4.0mm group, suggesting that although the magnitude of the absolute TLR difference between TAXUS and BMS was reduced in larger diameter vessels, the relative reduction was actually greater. Significant reductions in target vessel revascularization (TVR) and MACE were also reported in both small and larger diameter vessels. There were no statistically significant differences in the incidences of cardiac death, myocardial infarction or stent thrombosis.

"The risk for restenosis with BMS is generally decreased in large vessels, prompting some interventional cardiologists to choose BMS over DES in vessels larger than 3.5mm. However, since larger vessels also surround significant amounts of heart muscle tissue, even small differences in clinical events between BMS and DES may be clinically relevant," said Dr. Cox. "Our analyses of TAXUS IV and V data clearly add to the growing body of evidence that DES still appear clinically beneficial over BMS in the treatment of large vessels."

The safety and effectiveness of the TAXUS Express Stent has not been established in lesions with reference vessel diameters >3.75mm.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar wor
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
2. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
3. Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
4. Large Study Gives Nod to Drug-Eluting Stents in Heart Attack
5. Study Finds Repeated Episodes of Stent Thrombosis Common
6. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
7. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
8. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
9. St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable
10. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
11. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... and PITTSBURGH , Aug. 28, ... today announced that its shareholders have approved Mylan,s ... PRGO ; TASE) and the related issuance of ... extraordinary general meeting of shareholders held today. The ... at the extraordinary general meeting. In addition, the ...
(Date:8/28/2015)... , August 28, 2015 ... to reach USD 49.12 billion by 2020, growing at ... to a new report by Grand View Research, Inc. ... CAGR of 49.7% from 2014 to 2020. ... aging population along with rising incidences of chronic diseases ...
(Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... CINCINNATI, April 1, 2011 CarePoint Partners, one of ... in the United States, launched a food drive today ... the less fortunate in the communities where it operates. ... conducted throughout the month of April. CarePoint Partners is ...
... Inc. (OTCBB: PLCSF), a company focused on innovative medical ... REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ ... a.m. CT on Monday, April 4, 2011, at the ... & Expo in New Orleans, Louisiana. Additionally, PLC will ...
Cached Medicine Technology:CarePoint Partners Kicks Off Food Drive to Help Fight Hunger in Twenty-One Local Communities 2REMEDIAL II Results on PLC System's RenalGuard® to be Presented at ACC 2011's Late Breaking Clinical Trial Session 2REMEDIAL II Results on PLC System's RenalGuard® to be Presented at ACC 2011's Late Breaking Clinical Trial Session 3
(Date:8/29/2015)... ... 30, 2015 , ... Rio Salado College President Chris Bustamante announced ... President of Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for ... reach and impact through innovative technologies and strategies. , “I am very proud to ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... one of two inventors from Miller Place, N.Y. "I specialize in manual therapy, ... discomfort. In addition, it can be used for additional muscle dysfunction throughout the ...
(Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now available ... $49.00 was required to qualify for free standard shipping,” said Jennifer Ramirez, the public ... regardless of the item’s selling price.” , With competitive pricing in the e-commerce market ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also have ... through research to improve treatment outcomes. This localized treatment seems to address ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining ... County Memorial Hospital recently transitioned management companies to partner with Wound Care Advantage ... their outpatient wound center. , Transitioning wound care management providers can be ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... ... Enterprise Staffing and Scheduling Earned the Highest Score Based on Direct Product Evaluations and ... ... September 9, 2009 -- Today at the Nursing Management Congress2009, RES-Q® Healthcare Systems announced ...
... , WALTHAM, Mass., Sept. 9 ... research and advisory firms focusing on pharmaceutical and healthcare issues, ... messages among the ten surveyed osteoporosis brands likely as a ... commonly recalled that Sally Field promoted the brand or that ...
... , ATLANTA, Sept 9 The government,s ... improving health and appearance are still available. , , ... program offers a top-of-the-line skin rejuvenation and repair procedure - ... David R. Fern, FACS. Dr. Fern and the Vein & Skin ...
... , PRINCETON, N.J., Sept. 9 NephroGenex, Inc., ... announced the completion of patient enrollment in its Phase 2b clinical ... candidate Pyridorin(TM) (pyridoxamine dihydrochloride ) in type 2 diabetic patients ... have been randomized. , , The ...
... , , , ... -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) ... Caldolor((R)), an intravenous formulation of ibuprofen, designed primarily for use in ... available in the United States for the treatment of pain and ...
... ... partners with MSO packaging and Sun Chemical to provide comprehensive security solution which ... provide custom technology solutions which help prevent counterfeiting and diversion of products, within ... ...
Cached Medicine News:Health News:RES-Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 2Health News:Both Patients and Physicians Most Frequently Recall Roche's Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 2Health News:Both Patients and Physicians Most Frequently Recall Roche's Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 3Health News:'Cash For Crow's Feet' Program Offers Effective - and Affordable - Laser Skin Treatments 2Health News:NephroGenex Announces Full Enrollment in New Pyridorin(TM) Clinical Trial - PYR 210 2Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 2Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 3Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 4Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 5Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 6Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 7Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 2Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 3Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 4Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 5
Microwell-EIA for the detection of Insulin Autoantibody....
... screen shows you the way and ... is ready-to-go in any situation. ... calibration prior to each sample measurement. ... removable, rechargeable battery, which allows extended ...
... sets the standard for testing blood ... at your patient's side - the ... self contained system can easily be ... ICU, or wherever you need it ...
... Agitators feature sturdy, one-piece ... texture coating and provide ... your platelets. Helmer agitators ... used in Helmer incubators ...
Medicine Products: